Literature DB >> 25283521

Tissue distribution and ontogeny of multidrug resistance protein 2, a phosphatidylcholine translocator, in rats.

Qiuyang Zhang1, Wei Yang1, Hanlin Song1, Hui Wu1, Yang Lu1, Jiake He1, Di Zhao1, Xijing Chen2.   

Abstract

Multidrug resistance protein 2 (Mdr2), encoded by ATP-binding cassette b4 (Abcb4), serves as a phospholipid flippase that is indispensable for phosphatidylcholine translocation. However, little was known about the regulation of Mdr2 in Sprague-Dawley rats, although they are commonly used for pre-clinical investigation as well as mechanistic study. Present study aims at determining the tissue distribution, gender difference and ontogeny of Mdr2 in rats on both gene and protein levels. Results showed that Mdr2 was highly expressed in liver, modestly enriched in brain and testis, and less distributed in gastrointestinal tracts. Gender-divergent and male-dominated distribution was observed in the Mdr2 mRNA expression of liver and generative organs. Developmental pattern of rat Mdr2 on protein level was not exactly consistent with that on mRNA level. In conclusion, there was a considerable distribution of rat Mdr2 in the brain, testis and intestine besides liver, and the ontogeny of Mdr2 performed in an age-dependent pattern with the post-transcriptional regulation.

Entities:  

Keywords:  Distribution; Drug-induced liver injury; Multidrug resistance protein 2; Multidrug resistance protein 3; Ontogeny; Post-transcriptional regulation

Mesh:

Substances:

Year:  2014        PMID: 25283521     DOI: 10.1007/s13318-014-0226-5

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  12 in total

1.  Quality criteria for finding genes with high mRNA-protein expression correlation and coexpression correlation.

Authors:  Gabriel Ostlund; Erik L L Sonnhammer
Journal:  Gene       Date:  2012-02-04       Impact factor: 3.688

2.  Itraconazole-induced cholestasis: involvement of the inhibition of bile canalicular phospholipid translocator MDR3/ABCB4.

Authors:  Takashi Yoshikado; Tappei Takada; Takehito Yamamoto; Hiroko Yamaji; Kousei Ito; Tomofumi Santa; Hiromitsu Yokota; Yutaka Yatomi; Haruhiko Yoshida; Jun Goto; Shoji Tsuji; Hiroshi Suzuki
Journal:  Mol Pharmacol       Date:  2010-11-05       Impact factor: 4.436

3.  Developmental expression of canalicular transporter genes in human liver.

Authors:  Huey-Ling Chen; Hui-Ling Chen; Yu-Jung Liu; Chun-Hsiang Feng; Chao-Yi Wu; Ming-Kwang Shyu; Ray-Hwang Yuan; Mei-Hwei Chang
Journal:  J Hepatol       Date:  2005-09       Impact factor: 25.083

4.  Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers.

Authors:  J Taipalensuu; H Törnblom; G Lindberg; C Einarsson; F Sjöqvist; H Melhus; P Garberg; B Sjöström; B Lundgren; P Artursson
Journal:  J Pharmacol Exp Ther       Date:  2001-10       Impact factor: 4.030

5.  MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping.

Authors:  A J Smith; A van Helvoort; G van Meer; K Szabo; E Welker; G Szakacs; A Varadi; B Sarkadi; P Borst
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

6.  Human ATP-binding cassette transporter TaqMan low-density array: analysis of macrophage differentiation and foam cell formation.

Authors:  Thomas Langmann; Richard Mauerer; Gerd Schmitz
Journal:  Clin Chem       Date:  2006-02       Impact factor: 8.327

7.  Tissue distribution, gender-divergent expression, ontogeny, and chemical induction of multidrug resistance transporter genes (Mdr1a, Mdr1b, Mdr2) in mice.

Authors:  Yue Julia Cui; Xingguo Cheng; Yi Miao Weaver; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2008-10-14       Impact factor: 3.922

8.  Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis.

Authors:  T H Mauad; C M van Nieuwkerk; K P Dingemans; J J Smit; A H Schinkel; R G Notenboom; M A van den Bergh Weerman; R P Verkruisen; A K Groen; R P Oude Elferink
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

9.  Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid.

Authors:  Akira Honda; Tadashi Ikegami; Makoto Nakamuta; Teruo Miyazaki; Junichi Iwamoto; Takeshi Hirayama; Yoshifumi Saito; Hajime Takikawa; Michio Imawari; Yasushi Matsuzaki
Journal:  Hepatology       Date:  2013-04-05       Impact factor: 17.425

10.  Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human.

Authors:  Mark S Warren; Noa Zerangue; Katie Woodford; Lori M Roberts; Emily H Tate; Bo Feng; Cheryl Li; Thomas J Feuerstein; John Gibbs; Bill Smith; Sonia M de Morais; William J Dower; Kerry J Koller
Journal:  Pharmacol Res       Date:  2009-02-24       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.